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Welcome to the 2014 Clinical Investigators’ Day, sponsored by the Cornell University College of 
Veterinary Medicine.  The primary goal of this forum is to provide an opportunity for residents and 
interns to showcase ongoing investigations carried out at Cornell University College of Veterinary 
Medicine.  It is our hope that greater insights will be gained in the breadth and depth of clinical 
investigations conducted at the College and will serve as a catalyst to promote greater interactions 
among colleagues with clinical and basic science research interests.   
 
Organizing Committee 
Dr. Elizabeth Buckles, Co-Chair 
Dr. Jonathan Cheetham 
Mr. Kim Eaton  
Mr. Doug Fink 
Dr. Ursula Krotscheck 
Dr. Mary Martin, Co-Chair 
Dr. Santiago Peralta 
Dr. Tracy Stokol 
Dr. Rory Todhunter 
Ms. Judy Wood 
 
The organizing committee thanks the following individuals who contributed to the success of the Day: 
Mr. Jess Cisco 
Mr. Dave Frank 
Ms. Kathleen Hall 
Ms. Dionne Henderson 
Mr. Drew Kirby 
Ms. Amanda Mott 
Ms. Nancy Rice 
Dr. Meg Thompson 
Mr. Chad Westmiller 
 
 
 
Cover photo credits:  Optic nerve from Nidek, USA (http://usa.nidek.com/products/afc/attachment/211), 
red blood cells from geralt (http://www.wholewomanhealth.org/many-red-blood-cells-can-life-
threatening/), rainbow trout from Danny Ewing, and lambs from thrumyeye of Deviantart.com; 
remaining photos from Cornell University Photo. 
 
 
Disclaimer: The information presented in this publication comes exclusively from the contributing 
authors and their mentors identified in each abstract.  These abstracts are preliminary and should not be 
cited in bibliographies.  Material contained herein may be treated as personal communication and should 
be cited as such only with the consent of the author.  
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PROGRAM SCHEDULE 
 
Friday October 10, 2014 
Lecture Hall III, Veterinary Research Tower 
 
 
8:00am-8:30am Continental Breakfast  (Lecture Hall III, Veterinary Research Tower Foyer) 
8:35am-8:45am Welcome & Introductions – Dr. Elizabeth Buckles and Dr. Mary Martin, Co-Chairs 
8:45am-9:10am Presentation 
“CAREER PATHS TO ACADEMIA” 
Dr. Andrew Miller, Assistant Professor, Department of Biomedical Sciences 
and 
Dr. Robert Ossiboff, Postdoctoral Associate, Department of Population Medicine and Diagnostic Sciences 
 
9:15am-10:15am Resident Presentations – Moderated by Dr. Susan Fubini 
 9:15-9:30 PRESUMPTIVE FENBENDAZOLE TOXICOSIS IN THREE HOLSTEIN         Pg. 1          
CALVES  
    Emily Barrell – Large Animal Medicine Resident 
 
 9:30-9:45  ALTERED MICROBIOMES IN BOVINE DIGITAL DERMATITIS LESIONS,         Pg. 2 
    AND THE GUT AS A POTENTIAL RESERVOIR OF BACTERIAL PATHOGENS  
                Martin Zinicola – Ambulatory and Production Medicine Resident 
 
 9:45-10:00  ULTRASONOGRAPHIC MEASUREMENT OF THE OPTIC NERVE SHEATH        Pg. 3 
    DIAMETER IN HORSES  
    Stacy Cooley – Diagnostic Imaging Resident 
 
 10:00-10:15 SEMI-AUTOMATED COMPUTED TOMOGRAPHY MEASUREMENT OF         Pg. 4 
    TOTAL FAT AND VISCERAL FAT IN  LAMBS  
    Alana Rosenblatt – Diagnostic Imaging Resident 
 
10:15am-10:30am Break 
 
10:30am-11:30am Resident Presentations – Moderated by Dr. Natasza Kurpios 
 10:30-10:45 EVALUATION OF ANALGESIC EFFICACY OF FIROCOXIB, A SELECTIVE        Pg. 5 
    COX-2 INHIBITOR IN THE MOUSE MODEL OF INCISIONAL PAIN 
    Balu Reddyjarugu– Laboratory Animal Medicine Resident 
 
 10:45-11:00 EFFECTS OF VASOACTIVE THERAPY IN CONTINUOUS CARDIAC OUTPUT   Pg. 6 
    MONITORING BY PULSE CONTOUR-BASED ANALYSIS IN ANESTHETIZED PIGS 
    Alvaro Cisternas – Anesthesia Resident 
 
 11:00-11:15 TESTING THE EFFECTIVENESS OF NON-OPIOID ANALGESICS IN          Pg. 7 
RAINBOW TROUT (ONCORHYNCHUS MYKISS) SUBJECTED TO  
ANESTHESIA AND SURGERY 
    Amy Rizzo – Laboratory Animal Medicine Resident 
 
 11:15-11:30 PROTECTION AGAINST DIETARY FAT-INDUCED DNA DAMAGE BY THE      Pg. 8 
    FANCONI ANEMIA PATHWAY 
    Elizabeth Moore – Laboratory Animal Medicine Resident 
  
11:30am-12:30pm Lunch & Presentations 
 11:30-12:00 “GRADUATE TRAINING PROGRAM IN COMPARATIVE MEDICINE” 
                  Dr. John Parker, Associate Professor of Virology, Baker Institute for Animal Health 
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- and - 
“RESEARCH AND TRAINING OPPORTUNITIES BEYOND YOUR RESIDENCY” 
Dr. Bettina Wagner, Associate Professor of Immunology 
Associate Dean for Research and Graduate Education 
 
 12:00-12:30 “THE REAL DEAL IN PERFORMING CLINICAL RESEARCH” 
     Dr. N. Sydney Moise, Professor of Medicine, Cardiology 
   Section Chief, Cardiology, Department of Clinical Sciences 
 
12:30-12:45 Break 
 
12:45pm-1:30pm Resident Presentations – Moderated by Dr. Andrew Miller 
 12:45-1:00 CONVENTIONAL MONITORING OF NEUROMUSCULAR BLOCK IN        Pg. 9 
  ANESTHETIZED DOGS CANNOT RULE OUT RESIDUAL LARYNGEAL 
DYSFUNCTION 
    Daniel Sakai – Anesthesia Instructor 
 
 1:00-1:15  PULSE-PRESSURE-DERIVED CONTINUOUS CARDIAC OUTPUT         Pg. 10 
MONITORING CANNOT RELIABLE DETECT ACUTE SEVERE  
HEMORRHAGE IN A PEDIATRIC SWINE MODEL 
    Alvaro Cisternas –  Anesthesia Resident 
 
 1:15-1:30  REPORTING AND INTERPRETING RED BLOOD CELL MORPHOLOGY:        Pg. 11 
IS THERE DISCORDANCE BETWEEN CLINICAL PATHOLOGISTS AND 
CLINICIANS? 
    Ashleigh Newman – Clinical Pathology Resident 
 
1:30pm-1:45pm Break 
 
1:45pm-2:30pm Resident Presentations – Moderated by Dr. Erica Behling-Kelly 
 1:45-2:00 EVALUATION OF A NOVEL CYSTEINE-INACTIVATED          Pg. 12 
  NEUROMUSCULAR  BLOCKER IN CATS:  EFFECTS ON LARYNGOSPASM  
  AND HEMOGLOBIN SATURATION 
    Daniel Sakai – Anesthesia Instructor 
 
 2:00-2:15 COMPARISON OF BUPIVACAINE AND DEXMEDETOMIDINE FEMORAL        Pg. 13 
  AND SCIATIC NERVE BLOCKS VERSUS BUPIVACAINE AND  
  BUPRENORPHINE EPIDURAL FOR STIFLE ARTHROPLASTY IN DOGS 
     Annatasha Bartel – Anesthesia Resident 
 
 2:15-2:30  ASSESSMENT OF HEMATOLOGICAL CONCENTRATING CAPABILITIES        Pg. 14 
AND PLATELET ACTIVATION UTILIZING A COMMERCIAL PLATELET  
RICH PLASMA KIT ON CANINE BLOOD 
    Christopher Frye – Sports Medicine & Rehabilitation & Clinical Nutrition Resident 
 
2:30pm-3:20pm Key Note Speaker 
“MULTIDRUG-RESISTANT BACTERIAL INFECTIONS: 
FROM THE LAB TO THE PATIENT” 
Dr. Constança Pomba 
Associate Professor of Internal Medicine and Strategies of Antimicrobial Therapy 
at the Faculty of Veterinary Medicine of the University of Lisbon, Portugal 
 
3:20pm  Award Presentations and Reception 
   Dean Michael Kotlikoff, Austin O. Hooey Dean of Veterinary Medicine 
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Keynote Speaker 
 
Dr. Maria Constança Matias Ferreira Pomba, DVM, MSc, Ph.D., Associate 
Professor of Internal Medicine and Strategies of Antimicrobial Therapy at the 
Faculty of Veterinary Medicine of the Technical University of Lisbon, Portugal 
Dr. Pomba earned her DVM from the Faculty of Veterinary Medicine of the 
Technical University of Lisbon in 1991, her MSc in Tropical Veterinary Medicine 
and Zootecnis in 1994 and her PhD in Veterinary Science there in 2002.  Her area of 
research focuses on internal medicine, particularly in nephrology, urology and 
transfusion medicine and the study of antibiotic treatment of multidrug-resistant 
infections.  Current research interests include clonal dispersal of drug-resistant bacterial pathogens and 
surveillance of antimicrobial resistance and molecular epidemiology of antimicrobial resistance genes in 
bacteria of animal origin and their public health repercussions.  She heads a research group on 
Antimicrobial and Biocide Resistance at the Interdisciplinary Animal Health Research Centre, is the 
technical director of the Veterinary Blood Bank, and is responsible for the Laboratory of Resistance to 
Antibiotics and Biocides. 
Dr. Pomba is a founding member of Feline Medicine and Internal Medicine of the Portuguese 
Association of Veterinarians and a member of the European Society of Veterinary Internal Medicine and 
the European Society of Veterinary Nephrology and Urology.  She is vice-chair of the Antimicrobial 
Working Party and member of the Scientific Advisory Group on Antimicrobials of the European 
Medicine Agency.  Her research funding is derived from government and national programs in Portugal. 
 
Speakers 
 
Dr. Sydney Moise, DVM, MS, Professor of Medicine, Chief of the Section of 
Cardiology, Department of Clinical Sciences, Cornell University  
Dr. Moise received her DVM degree from Texas A&M University and an 
MS degree from Cornell University.  She is board certified in both Cardiology and 
Internal Medicine from the American College of Veterinary Internal Medicine and is 
a member of the European Society of Veterinary Cardiology.  Dr. Moise established 
the clinical program in veterinary cardiology at Cornell University and as the 
Director of the Cardiology Residency which has the primary mission of training 
future academic veterinary cardiologists.  Dr. Moise’s research has centered on spontaneous cardiac 
rhythm (normal and abnormal) in dogs, and recently has been involved in studies to understand the 
mechanisms of degeneration of the mitral valve in dogs.  She was awarded the AVMA research award 
for arrhythmia studies and the Bourgelat Award for international contribution to the clinical practice of 
veterinary medicine.  For more than five years Dr. Moise was Editor-in Chief of the international 
Journal of Veterinary Cardiology where she is now Associate Editor. She has authored more than 100 
journal articles and book chapters.  She is a past Norden Distinguished Teacher awardee and is 
extensively involved in the international aspects of academic veterinary cardiology including speaking 
world-wide, international organizations and training. 
 
Robert “Oz” Ossiboff, DVM, PhD, DACVP, Postdoctoral Associate, Department of 
Population Medicine and Diagnostic Sciences, Section of Wildlife and Exotic 
Animal Medicine, Cornell University 
Dr. Ossiboff graduated from Cornell’s combined DVM/PhD program in 
2010, receiving his Ph.D. in Comparative Biomedical Science studying 
virus:receptor interactions and virulence determinants in feline calicivirus. He 
subsequently entered Cornell’s Anatomic Pathology residency, where he completed  
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the first two years of his training, followed by an additional year of residency training at the Wildlife 
Conservation Society’s Bronx Zoo. He was certified as a Diplomate of the American College of 
Veterinary Pathologists in 2013.  Following the completion of his residency, Dr. Ossiboff completed a 
one year Fellowship in Molecular Pathology also at the Wildlife Conservation Society.  
He recently accepted a postdoctoral research associate position in the Animal Health Diagnostic 
Center with Dr. Elizabeth Bunting and Dr. Ed Dubovi, where he will be investigating chytridiomycosis 
in Eastern Hellbenders in addition to working on a project establishing cell lines of exotic and 
endangered species with Dr. John Parker at the Baker Institute for Animal Health.  As a veterinary 
student, “Oz” participated in the College’s Leadership Program for Veterinary Students and the Cornell 
Veterinary Investigator Program.  He was the recipient of the Anna Olafson Sussex Pathology Award in 
2009, the Jacob Traum Award in 2010, and the CL Davis Scholarship award in 2012. His research 
interests include infectious diseases of exotic species and wildlife, with a particular interest in diseases 
of reptiles and amphibians. Oz has 12 peer reviewed publications. 
 
 
John Parker, BVMS, Ph.D., Associate Professor of Virology, Baker Institute for 
Animal Health, Cornell University 
Dr. Parker received his B.V.M.S. from the University of Glasgow, Scotland, 
in 1983 and held several international positions including consulting for the Cornell 
University Feline Health Center prior to receiving his Ph.D. from Cornell in 
1999.  Post-Doctoral research at the Baker Institute for Animal Health and Harvard 
Medical School followed.  Dr. Parker also held an instructor position at the Harvard 
Medical School before joining the Cornell faculty at Baker Institute for Animal 
Health in 2003. 
Fostering the career development of tomorrow’s veterinary scientists is important to Dr. 
Parker.  He has been an advisor to 19 graduate students, mentored more than 20 undergraduate students, 
and 9 post-doctoral associates/fellows in his laboratory.  Dr. Parker teaches both undergraduates and in 
the veterinary curriculum. He is also the director of the Cornell Leadership Program for Veterinary 
Students and is director of the NIH supported institutional research training grant entitled “Graduate 
Training Program in Comparative Medicine.” The latter is geared towards advanced research training of 
specifically for veterinarians. 
Dr. Parker studies viruses and the ways in which animals respond to viral infection, laying the 
basic science groundwork for ways to improve diagnosis, treatment, and prevention of these diseases. 
His lab is focused on viruses that infect humans and animals, including reovirus and feline calicivirus, 
and the results of most of his projects can be broadly applied to benefit the health of animals and 
humans alike. His work has been supported by the Morris Animal Foundation, the Winn Foundation, 
The Burroughs Wellcome fund, US –Israel Binational Agricultural Research Development Fund, and 
the NIH. 
 
 
Bettina Wagner, DVM, Dr. vet. med. Habil., Associate Professor in Immunology, 
Department of Population Medicine and Diagnostic Sciences; Associate Dean for 
Research and Graduate Education, Cornell University 
Dr. Wagner was awarded her DVM in 1990 and Dr. vet. med. in Veterinary 
Immunology in 1993 from the School of Veterinary Medicine, Hannover, 
Germany.  She has held several fellowships and research positions nationally and 
internationally.  She was a visiting professor and Senior Research Associate at the 
Baker Institute for Animal Health prior to joining the Population Medicine and 
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Diagnostic Sciences faculty in 2006.  Dr. Wagner was the named the 2009-2011 Harry M. Zweig 
Assistant Professor in Equine Health.  Dr. Wagner is first author on dozens of peer-reviewed articles, 
has been awarded several international patents and is  the Director of the Serology/Immunology section 
at Cornell’s Animal Health Diagnostic Center.   
Dr. Wagner’s laboratory focuses on research in equine immunology. She is particularly 
interested in immune responses and protective mechanisms in neonates and young foals. The disease 
models include intracellular pathogens, such as Equine herpesvirus type 1 (EHV-1), and allergic 
diseases especially Culicoides induced skin hypersensitivity. Major pathways that are investigated by 
her group are adaptive T-cell immunity, antibody isotype responses and cytokine regulation. Another 
major goal is the development of new immune reagents for horses and advanced technologies in 
veterinary diagnostics, such as the Lyme Multiplex assays for horses and dogs and assays for other 
infectious diseases, cytokines and immunoglobulin isotypes.  Her grant funding has been derived from 
the USDA and Harry M. Zweig Memorial Fund for Equine Research. 
 
 
Andrew Miller, DVM, Assistant Professor of Anatomic Pathology and the Anne 
Groot Sesquicentennial Fellow, Department of Biomedical Sciences, Cornell 
University 
Dr. Miller joined the Cornell faculty in the fall of 2013.  He completed a 
residency in veterinary anatomic pathology at Cornell in 2008 following the 
completion there of his DVM.  Afterwards, he joined the faculty at the New England 
Primate Research Center, a division of Harvard Medical School, and simultaneously 
held an appointment in the Pathology Department of the Massachusetts General 
Hospital.  He is a diplomate of the American College of Veterinary Pathologists (ACVP), and is 
involved nationally in the ACVP through the examination committee and other committees related to the 
national ACVP meeting.  Dr. Miller’s research is focused on studying mechanisms underlying 
neurologic disease, especially neoplasia, in companion animals focusing primarily on dogs.  This is 
being done through histologic, immunohistochemical, and molecular studies between analogous tumors 
in dog and man.  He maintains numerous collaborations with researchers at Beth Israel Deaconess 
Medical Center, Boston College, University of Georgia, and University of California, Davis.  Dr. Miller 
has a strong interest in training veterinary students and pathology residents and preparing them for a 
career in comparative veterinary pathology.  He believes this is best done through hands-on exposure to 
clinical cases and basic research techniques and strongly believes in the integration of these modalities 
into teaching. 
 
Moderators 
 
Andrew Miller, DVM, Assistant Professor of Anatomic Pathology and the Anne 
Groot Sesquicentennial Fellow, Department of Biomedical Sciences, Cornell 
University 
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Erica Behling-Kelly, DVM, PhD, Assistant Professor of Clinical Pathology, 
Department of Population Medicine and Diagnostic Sciences, Cornell University 
Dr. Behling-Kelly has been an Assistant Professor of Clinical Pathology since 
2011 after finishing a residency in Veterinary Clinical Pathology at the University of 
Wisconsin, Madison where she also received her Ph.D. in 2006 in Comparative 
Biomedical Sciences. She received her DVM in 2002 from the School  of Veterinary 
Medicine, University of Georgia.  She holds several memberships in professional 
associations including the International Society of Thrombosis and Hemostasis and 
diplomate status in the American College of Veterinary Pathologists.   
Her research interests include Lipoproteins as markers and modulators of disease in domestic 
species, vascular biology, hemostasis and thrombosis, and molecular determinants of aggressive 
biological behavior in neoplastic cells. As a clinical pathologist, she is interested in advancing our 
understanding of disease processes as well as improving our ability to diagnose disease. Her laboratory 
currently focuses on determining the pathogenic potential and diagnostic utility of serum lipoproteins in 
domestic species. In two on-going projects, she is investigating lipoproteins in the dog, relative to their 
ability to promote thrombosis in hyperlipidemic diseases (such as hyperadrenocorticism) and the 
progression of renal disease. Other projects underway include investigating changes in lipoproteins 
during various life-stages in dairy cows and investigating the role of the erythrocyte and hemolysis in 
promoting thrombosis in the dog. 
 
Susan L. Fubini, DVM, Professor of Large Animal Surgery, Section Chief of 
Large Animal Surgery, Department of Clinical Sciences, Cornell University 
Dr. Fubini received her DVM in 1980 and was recognized as Alumna of the 
Year in 2013 from the University of Georgia.  She completed her three-year intern 
and resident training at Cornell University prior to joining the College faculty.  Dr. 
Fubini was appointed the College’s Associate Dean for Academic Affairs in 2013. 
She is a member of the Board of Regents of the American College of 
Veterinary Surgeons.  She has served as a member of the College of Veterinary 
Medicine’s College Research Council and was the Associate Chair for Promotion, Tenure, and 
Mentoring in the Department of Clinical Sciences.  Dr. Fubini has mentored more than 50 interns and 
residents during her tenure at the College and in 1990 received the Norden Distinguished Teacher of the 
Year award.  Fubini has co-authored a leading farm animal surgery text, authored or co-authored nine 
book chapters, and lead or co-authored 79 published studies. On dozens of occasions, she has accepted 
invitations to share her expertise at regional, state, national, or international conferences. 
 
Natasza Kurpios, Ph.D., Robert Hovey Udall Assistant Professor, Department of 
Molecular Medicine, Cornell University 
 Dr. Kurpios was appointed assistant professor in the Department of Molecular 
Medicine in the College of Veterinary Medicine in 2009.  She received her Ph.D. in 
Biochemistry and Biomedical Sciences at McMaster University, Hamilton, Ontario, 
and completed a postdoctoral fellowship at Harvard Medical School. 
Currently, her research program addresses problems in developmental biology, 
specifically the mechanisms that drive intestinal coiling and vascular development of 
the midgut.  Actively engaged with peers in the Vertebrate Genomics Group and the Cornell Stem Cell 
Program, Dr. Kurpios also collaborates with computational biologists and bioengineers across campus to 
model developmental changes and analyze the mechanical properties of tissue matrices influencing 
organ growth. 
ix 
 
Judges 
 
Rodrigo Carvalho Bicalho, DVM, PhD, Assistant Professor of Dairy Production 
Medicine, Department of Population Medicine and Diagnostic Sciences, Cornell 
University 
Dr. Bicalho received his Ph.D. in 2008 in Comparative Biomedical Sciences from 
Cornell University College of Veterinary Medicine. After being awarded his DVM 
in 2002 from the Federal University of Goiás, Brazil, he completed a residency in 
Ambulatory and Production Medicine at Cornell. He is a member of several 
professional organizations both nationally and internationally, including the 
Lameness Committee of the American Association of Bovine Practitioners, American Dairy Science  
Association, and Regional Council of Veterinary Medicine, Goiás, Brazil.  His research interests include 
production medicine, epidemiology, and microbiology. He has four primary focus areas:  a) Bovine 
lameness, metritis, and mastitis. b) Factors affecting reproductive efficiency in dairy cows. c) Estrous 
synchronization. d) Microbial genomic and metagenomic study of infectious diseases.  His work is 
supported by the USDA and corporate sponsors.  Dr. Bicalho has 6 graduate students, 3 postdoctoral 
associates, and 3 residents in training.  He was recently named the 2014 Zoetis Animal Health Award in 
Research Excellence recipient. 
 
Ricardo de Matos, LMV, Lecturer in Zoological Medicine, Department of 
Clinical Sciences, Cornell University 
Dr. de Matos received his LMV, graduating first in class, from the 
Faculdade de Medicina Veterinaria, Lisbon, Portugal in 2002. He completed an 
internship in Zoo, Wildlife and Exotic Animal Medicine in 2004 and a residency in 
Exotic Animal Medicine and Surgery in 2006 at Cornell University Hospital for 
Animals.  Dr. De Matos received the 2006 Presentation Excellence Award from the 
first annual Resident Research Seminar.   
In 2007, in collaboration with the Roswell Park Cancer Institute, he completed a Postdoc in 
medical oncology in the Department of Clinical Sciences, under the leadership of Professor Rodney 
Page. His efforts focused on investigating ovarian cancer in the avian model.  He is a diplomate of the 
American Board of Veterinary Practitioners, Avian specialty, the European College of Zoological 
Medicine -Avian specialty, and European College of Zoological Medicine -Small Mammal specialty.  
He began his position as lecturer in 2008 and his special interests include medical oncology, backyard 
poultry medicine and surgery, and analgesia. 
 
Rodney R. Dietert, Ph.D., Professor of Immunotoxicology, Department of 
Microbiology and Immunology, Cornell University 
Dr. Dietert received the BS degree in Zoology from Duke University in 1974 
and his Ph.D. from University of Texas at Austin in 1977.  Dr. Dietert has been the 
Director of Graduate Studies for the Graduate Field of Immunology, Director of the 
Institute for Comparative and Environmental Toxicology, Director of the Program on 
Breast Cancer and Environmental Risk Factors and President of the 
Immunotoxicology Specialty Section of the Society of Toxicology. 
Dr. Dietert’s research and public health interests concern the protection of children from immune 
dysfunction-based chronic diseases. His initiatives include the study of developmental immunotoxicity 
of environmental chemicals and drugs and the adverse outcomes that result, identification of patterns of 
interlinked chronic diseases, improved approaches for immunotoxicity testing to protect against chronic 
diseases, application of fractal biology to the assessment of immune status and intervention strategies 
that can reduce the risk of chronic disease comorbidities during aging. 
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(Judges Continued – Deitert) 
Dr. Dietert designed and co-taught the course Tools for a Lifelong Career in Research, which 
emphasizes contemplative practices to make the most of a researcher’s career, for which he won the 
inaugural Excellence in Teaching Award for undergraduate and graduate teaching.  With his wife Janice, 
Dr. Dietert authored Science Sifting: Tools for Innovation in Science and Technology which provides 
tools and strategies to facilitate creative thinking and innovation among scientists. 
 
Angela L. McCleary-Wheeler, DVM, PhD, Assistant Professor of Oncology, 
Department of Clinical Sciences, Cornell University 
Dr. McCleary-Wheeler is a recently appointed faculty member, having 
completed her 2014 Ph.D. in Biochemistry and Molecular Biology at the Mayo 
Graduate School College of Medicine.  She is a 2011 Board Certified Oncologist and 
served for three years as a medical oncology resident at the North Carolina State 
College of Veterinary Medicine following a rotating small animal internship at the 
University of Missouri-Columbia College of Veterinary Medicine in 2005-2006.  
She received her DVM from Iowa State University.  
Dr. McCleary-Wheeler’s research interests focus on uncovering the molecular mechanisms 
driving cancer development and progression through detailed investigations into the regulatory 
mechanisms governing gene expression.  She applies this approach to the study of the regulation and 
function of the oncogene GLI2.  Her laboratory seeks to describe and understand the molecular 
mechanisms governing the activity of the GLI2 gene in cancer cells.   
As veterinary medical oncologist, Dr. McCleary-Wheeler is also interested in how we can apply 
what is learned in the laboratory to our companion animals diagnosed with cancer, providing an 
opportunity to interact with both basic science researchers as well as clinicians. Finally, she enjoys 
teaching and interacting with students and trainees both in the laboratory and the clinic settings. 
 
Scott Palmer, VMD, Adjunct Professor, Department of Population Medicine & 
Diagnostic Sciences, Cornell University; New York State Equine Medical 
Director 
Dr. Palmer is a renowned veterinarian from New Jersey with more than three 
decades of experience in providing medical care for horses.   As the recently 
appointed New York State Equine Medical Director, Dr. Palmer oversees the health 
and safety of horses at all New York State Thoroughbred and Standardbred 
racetracks. 
  Since graduating from the University of Pennsylvania, School of Veterinary Medicine in 1976, 
Dr. Palmer has worked as a staff clinician at the New Jersey Equine Clinic, serving as the Hospital 
Director from 1997 through 2013. He is a two-time recipient of the New Jersey Equine Practitioners 
Veterinarian of the Year award, as well as a recipient of the AAEP President’s Award in 2009 and the 
AAEP Distinguished Service Award in 2010. 
  Dr. Palmer is board certified in equine practice by the American Board of Veterinary 
Practitioners. He has authored dozens of peer-reviewed publications and is a featured speaker at 
veterinary conferences world-wide. He is a member of several professional organizations and has held 
leadership positions in many, including the American Veterinary Medical Association, the American 
Association of Equine Practitioners, the American Board of Veterinary Practitioners, the New Jersey 
Veterinary Medical Association, and the New Jersey Association of Equine Practitioners.  Dr. Palmer 
chaired the New York Task Force on Racehorse Health and Safety, which was formed at the request of 
Governor Andrew M. Cuomo in 2012 in the wake of 21 equine fatalities during Aqueduct’s 2011-12 
Winter Meet. 
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Abstract Title:  PRESUMPTIVE FENBENDAZOLE TOXICOSIS IN THREE HOLSTEIN CALVES 
 
Authors Names: 
Emily A. Barrell1, Rebecca E. Ruby2, Belinda Thompson3, Theresa Southard2, Gillian A. Perkins1 
1Department of Clinical Sciences, Cornell University, Ithaca, New York 
2Department of Biomedical Sciences, Cornell University, Ithaca, New York 
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Project Mentor: 
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Abstract: 
Fenbendazole, a benzimidazole that interferes with microtubule formation, is a widely used 
anthelminthic agent that is considered safe in ruminants.  Albendazole, a closely related compound, 
interferes with mitotic activity in rapidly dividing cells, resulting in bone marrow hypoplasia and 
intestinal crypt epithelial necrosis.  This abstract describes the clinical findings and necropsy 
examinations of three 2-month old Holstein calves that suffered adverse reactions secondary to 
fenbendazole administration.  Prior to presentation, all three had received approximately four times the 
labeled dose of fenbendazole for presumptive Giardia-induced diarrhea.  Progression of signs prompted 
referral, and two of the three animals were presented for evaluation.  Signs included fever, tachycardia, 
dyspnea, profuse diarrhea, and recumbency.  All three animals exhibited absolute neutropenia on 
hemogram.  Despite treatment, one calf was euthanized due to poor response and one calf died.  The 
third calf was treated on-farm and recovered over several weeks.  Histologic examination of liver, lung, 
and intestinal epithelial cells revealed hyperplasia, cell atypia, mitotic figures that were often irregular, 
and/or ring mitosis and abnormally clumped chromatin.  The bone marrow had severe changes with an 
overall cellularity of less than 5%.  The feces were negative for Salmonella spp, bovine viral diarrhea 
virus, rotavirus, and parasites, and positive for bovine coronavirus.  Based on histopathology and history 
of multiple animals affected, a toxic etiology was suspected.  Based on clinical history the only common 
exposure among the three affected calves was repeated administration of high dose fenbendazole.  This 
suggests that judicious use of fenbendazole in calves is warranted.  
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Abstract Title:  ALTERED MICROBIOMES IN BOVINE DIGITAL DERMATITIS LESIONS, AND 
THE GUT AS A POTENTIAL RESERVOIR OF BACTERIAL PATHOGENS 
 
Authors Names: 
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1Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, New York  
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Abstract: 
Introduction 
Bovine digital dermatitis (DD) is the most relevant infectious disease associated with lameness affecting 
the welfare of cattle worldwide. Here, we characterize the microbiome of healthy skin and lesions from 
dairy cows affected with different stages of DD and we also identified DD-causing Treponema in rumen 
and fecal samples. 
Material and Methods 
A total of 140 biopsies (51 healthy skin and 89 DD lesions) samples were collected from Holstein dairy 
cows housed in three different dairy farms. Rumen fluid (n= 8) and fecal (n=14) samples were also 
collected. DNA was extracted and the microbiome was determined by shotgun and 16S metagenomic 
techniques using Illumina MiSeq platform.    
Results and Discussion 
Discriminant analysis revealed that microbiomes of healthy skin, active and inactive DD lesions were 
completely distinct. Treponema spp. were found in greater relative abundance in active DD lesions when 
compared with healthy skin and inactive DD lesions and these Treponema species were nearly 
ubiquitously present in rumen and fecal microbiomes. Candidatus amoebophilus asiaticus, a bacterium 
not previously reported in DD lesions, was encountered in high relative abundance in active and inactive 
lesions but not in healthy skin. In conclusion, our results indicate that there is particular group of six 
Treponema spp. (T. denticola, T. maltophilum, T. medium, T. putidum, T. phagedenis and T. 
paraluiscuniculi) that dominate active DD lesions and these Treponema species are nearly ubiquitously 
found in rumen and fecal microbiomes, suggesting that the gut could be a reservoir for microbes 
involved in DD pathogenesis. 
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Abstract: 
Early diagnosis of elevated intracranial pressure (ICP) and the ability to monitor treatment response is 
critical to preventing progressive brain injury due to ICP induced reduction in cerebral perfusion. In 
people, the detection of enlargement of the optic nerve sheath diameter (ONSD) by transpalpebral 
ultrasonography is a highly accurate test for elevated ICP. Additional benefits are noninvasiveness, 
accessibility, affordability, and lack of requirement for general anesthesia. Our study aims were to 
demonstrate the feasibility of making this measurement stall-side in live horses and establish a reference 
range based on age and body weight. The study design was prospective, observational, and cross-
sectional. Two blinded observers used ultrasonography to measure the ONSD of both eyes of horses of 
various ages and body weights and without clinical signs of ocular disease or elevated ICP. 
Repeatability was assessed as the mean difference of duplicated measures. Agreement within and 
between observers was assessed using Bland-Altman plot analysis. Correlation between ONSD and age 
or body weight was assessed using Pearson’s correlation. The sample population consisted of 31 horses 
of different breeds. In all horses, the ONSD ranged between 3-6 mm for both eyes and both observers. 
The mean difference (limits of agreement) between measures of ONSD by two observers was -0.1 (-0.8 
to 0.7) mm for the left and 0.0 (-0.8 to 0.8) mm for the right eyes. ONSD increased with age and body 
weight (P<0.02). Ultrasound measurement of ONSD was repeatable and should be evaluated further for 
its ability to identify horses with high ICP.  
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Abstract: 
Body fat content is a predictor or outcome of disease, metabolic processes, and therapeutic responses. 
Computed tomography (CT) allows noninvasive measurement of body fat, with differentiation of 
metabolically active visceral fat from total fat. Common protocols in people whereby fat percentages are 
estimated from a single CT slice might be an invalid assessment of whole-body values, and is unlikely 
repeatable in growing animals. An alternative is acquiring whole-body volumetric data, which is easily 
obtained using modern CT scanners but laborious to analyze manually. The aim of this method 
comparison study was to compare semi-automated computer analysis of whole-body volumetric CT data 
to carcass analysis in lambs, which are a model for intrauterine growth retardation. Twelve lambs 
underwent duplicate whole-body CT, euthanasia, and carcass analysis by dissection and chemical 
analysis. CT measures of total-fat and visceral-fat content were obtained using a newly developed semi-
automated computer algorithm. Agreement between methods was assessed by Bland-Altman plot 
analysis. CT systematically underestimated total-fat and visceral-fat weights compared to chemical 
analysis, and the limits of agreement exceeded ±10% of the mean fat weight. Compared to dissected 
weight, CT produced similar results for visceral-fat weight. The two CT acquisitions were repeatable for 
total-fat and visceral-fat volume, as the mean difference of repeated measures was approximately zero. 
Carcass analysis and semi-automated CT measurement are not interchangeable for quantifying body fat 
contents. However, we predict that CT can be used to monitor relative changes in body fat serially in the 
same lamb because the measures are noninvasive and repeatable.  
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Abstract: 
Pain management in laboratory animals is generally performed using opioids and/or non-steroidal anti-
inflammatory (NSAID) drugs.  However, opioid use is hindered by controlled substance requirements 
and a relatively short duration of action.  In this study, we evaluated the analgesic efficacy of firocoxib 
(a COX-2 selective NSAID) relative to buprenorphine in the mouse model of plantar incisional pain by 
objective measurement of mechanical allodynia and thermal hyperalgesia using electronic von Frey and 
Hargreaves equipment, respectively. Our experimental design included five groups (n=10 mice/group) – 
i) Firocoxib @10 mg/kg (F10) i.p. every 24 hours [q24h], ii) Firocoxib @20 mg/ kg (F20) i.p. q24h, iii) 
Buprenorphine @0.2mg/kg (Bup) s.c. q8h, iv) Normal Saline i.p. q24h and v) sham group (anesthesia, 
no incision) treated with firocoxib 20 mg/kg i.p. once q24h. All mice underwent nociceptive response 
assays examining mechanical allodynia and thermal hyperalgesia at -24 (baseline), 4, 24, 48 and 72 
hours post-surgery. All drugs were administered preemptively and continued up to 72 hours post-
surgery.  Buprenorphine provided alleviation (p<0.05) from allodynia at all-time points post incision. 
F10 alleviated allodynia at 4, 24, and 48h post-incision while F20 alleviated allodynia at 24, 48, and 
72h. For thermal hyperalgesia, none of the drug groups provided alleviation at 4h. With the exception of 
F10 at 24h (P=0.19), thermal hyperalgesia was alleviated for all drug groups at 24, 48, and 72h. Thus, 
our results indicate that once daily firocoxib administration alleviates pain resulting from soft tissue 
injury in mice and may be a suitable alternative to buprenorphine dosing at q8h. 
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Abstract: 
Continuous cardiac output (CO) facilitates clinical decision making in hemodynamically unstable 
patients.  However, pulse pressure-based CO might be susceptible to changes in the pressure waveform 
induced by vasoactive therapies. We examined whether it is necessary to recalibrate a pulse pressure-
based CO monitor during vasoactive therapy.  
 
Ten piglets (6.6-10.1 kg) were anesthetized with dexmedetomedine, ketamine and isoflurane.  Initially 
CO was measured by transpulmonary ultrasound-dilution. Thereafter, continuous CO was obtained 
simultaneously with two monitors from the same femoral arterial waveform; one monitor was 
recalibrated (COCAL) after each vasoactive intervention while the other monitor was not recalibrated 
(CONOCAL).  Piglets received phenylephrine (PE; 1 or 3 µg kg-1 m-1) and sodium nitroprusside (SNP; 1 
or 5 µg kg-1 m-1), in random order.  CO, HR, MAP, and systemic vascular resistance (SVR) during each 
infusion were compared with baseline values (paired t-tests).  Bias, limits of agreement (LOA) and 
percentage error between simultaneous COCAL and CONOCAL were examined with Bland-Altman plots. 
 
PE infusion significantly increased CO (43.8%), HR (36.8%), and MAP (43.1%), while SNP 
administration did not produce significant changes.  There was no bias between monitors at baseline; but 
bias decreased to -0.025 and -0.021 L m-1 during PE and SNP administration, respectively.  The LOA 
increased substantially during drug administration.  Percentage error increased from ≤5.3% at baseline 
to 32% and 27% during PE and SNP, respectively. 
 
Even mild changes in arterial blood pressure and CO adversely affected the performance of an 
uncalibrated continuous CO monitor.  Pulse pressure-based CO monitors should be recalibrated during 
vasoactive therapy. 
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Abstract: 
Techniques to manage pain in fish are still in their infancy. Opioid analgesics have been shown to 
ameliorate aversive behaviors and physiologic changes when fish are exposed to noxious stimuli. 
However, the opioid agents are controlled substances requiring special licensing, reporting requirements, 
and security measures. If non-controlled agents such as nonsteroidal anti-inflammatory drugs (NSAIDs) 
can be proven safe and effective, this may encourage wider use of analgesics in fish.  To determine the 
effectiveness of three different NSAIDs in managing pain, 48 rainbow trout underwent an exploratory 
celiotomy using MS-222 anesthesia. Fish were randomly assigned to one of 4 treatment groups with 12 
fish per group: flunixin (0.5 mg/kg), ketorolac (0.5 mg/kg), ketoprofen (2 mg/kg), or saline. At specific 
time points before and after surgery the behavior of the fish was monitored for vertical position in the 
water, respiratory rate, and response to food (presentation of three pellets). Clinical pathology was 
assessed one week before surgery and 48 hours after surgery. Fish were euthanized at 14 days after 
surgery using MS-222 and tissues were collected for histopathology. No significant differences existed 
between the treatment groups for behavioral observations or histopathology. In evaluating clinical 
pathology, postoperative phosphorus levels were shown to be significantly higher in the control saline 
treatment group than the flunixin treatment group. Although the NSAID treatments were not proven to 
be more effective in managing pain than the saline treatment, it was demonstrated that the NSAIDs had 
no adverse effects on the health of the fish. 
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Abstract: 
Fanconi anemia (FA) is a genomic instability syndrome affecting 1 in 131,000 people in the U.S.  FA 
phenotypes include developmental defects, bone marrow failure, cancer predisposition, and metabolic 
disorders. The FA pathway becomes activated by DNA replication stresses and plays a major role in 
responding to interstrand DNA crosslinks (ICLs).  FA patients are hypersensitive to exogenous 
genotoxins; however, the endogenous sources of damage repaired by the pathway remain poorly 
characterized. We tested the hypothesis that the FA pathway protects against DNA damage caused by 
lipid metabolism using a mouse model lacking FancD2, which encodes a central component of the 
pathway. Fancd2-/- and wildtype (WT) mice were continued on standard diet (SD) or challenged with a 
high fat, high cholesterol diet (HFD) at weaning, which rapidly led to hepatic steatosis and hepatitis.  In 
a long term HFD trial, Fancd2-/- mice had decreased survival compared to WT mice (p=0.01). A 
preliminary cohort of Fancd2-/- mice fed HFD for ten weeks had increased  hepatic pathology relative to 
WT controls, including bile duct hyperplasia, neutrophil infiltration, and lipogranuloma formation, and 
hepatocellular apoptosis, suggesting that the FA pathway plays a role in protecting against HFD induced 
damage. We propose that reactive oxygen species and lipid peroxidation products, which can cause 
DNA damage including ICLs, are a source of endogenous damage repaired by the FA pathway. The 
HFD hypersensitivity in Fancd2-deficient mice described here provides a powerful opportunity to define 
the roles of the FA pathway in protecting against HFD-induced DNA damage. 
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Abstract: 
Incomplete recovery from neuromuscular blocking agents (NMBA) increases the risks for upper airway 
collapse, hypoxia and tracheal aspiration.  Conventionally, recovery of laryngeal function from NMBA 
is not measured directly; instead, neuromuscular function is measured at a limb and the findings 
extrapolated.  We compared recovery times from rocuronium-induced block at the larynx with those at 
the pelvic limb in dogs. 
 
Six adult beagles (two males), 7.6-9.4 kg, were anesthetized with dexmedetomidine and isoflurane.  
Neuromuscular block was induced with 0.6 mg kg-1 rocuronium, intravenously.  The peroneal and 
recurrent laryngeal nerves were stimulated simultaneously in a train-of-four (TOF) mode every 15 
seconds and the amplitudes of the electromyographic (EMG) responses were measured.  Fade during 
TOF (TOFFADE) was quantified to assess adequacy of recovery from the NMBA.  Time from 
rocuronium injection to spontaneous recovery of TOFFADE to 0.7 and 0.9 at the larynx and pelvic limb 
were compared with paired t-tests, alpha = 0.05. All data were parametric. 
 
Recovery to TOFFADE of 0.7 took 30.8 ± 8 (mean ± SD) and 46.2 ± 16 minutes at the pelvic limb and 
larynx, respectively, (p < 0.02).  The time to TOFFADE 0.9 was 34.5 ± 8 and 52.5 ± 19 minutes at the 
pelvic limb and larynx, respectively (p < 0.02). 
 
We conclude that during spontaneous recovery from NMBA return of the EMG evoked in the larynx is 
delayed substantially with regard to that in the pelvic limb.  Hence, when the limb is fully recovered, the 
protective reflexes of the larynx are likely still obtunded. 
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Abstract: 
Cardiac output can be calculated continuously from the pulse pressure waveform (CCOPP) using 
coefficients based on hemodynamic models.  Calibration of CCOPP might be required during 
hemodynamic changes due to alterations in pulse pressure waveforms.  The purpose of the study was to 
compare uncalibrated CCOPP with CO measured by the transpulmonary ultrasound dilution technique 
(COUD) during blood depletion/repletion. 
 
In eight anesthetized piglets (7.9±1.16 kg) both COUD (Stewart Hamilton method) and CCOPP  were 
measured simultaneously at baseline, after sequential removal of 15 and 30ml kg-1 of blood, and after 
volume replacement (30ml kg-1 of blood).  CCOPP was not recalibrated during these procedures.  The 
effects of blood volume depletion/repletion on COUD, MAP, HR and systemic vascular resistance (SVR) 
were evaluated with ANOVA for repeated measures. Bias and limits of agreement (LOA) between 
paired COUD and CCOPP values were assessed with Bland-Altman plots. The ability of CCOPP to track 
changes during hemorrhage and blood administration was analyzed with a 4-quadrant plot.  Pigs were 
euthanized after data collection. 
 
Blood depletion (15 and 30ml kg-1) significant decreased COUD and MAP (p < 0.05) with no significant 
changes in HR or SVR.  After blood repletion, all values returned to baseline except MAP, which 
exceeded baseline.  During hemorrhage, CCOPP overestimated COUD by 25-68%, with wide LOA.  
During blood depletion or repletion, CCOPP did track changes in COUD only 77% of the time. 
 
Recalibration of CCOPP is necessary if blood volume changes substantially. Uncalibrated CCOPP cannot 
reliably detect reductions in blood volume. 
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Abstract: 
Background  Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to assist clinicians 
in prioritizing differential diagnoses. However, reporting is subjective, semi-quantitative, and potentially 
biased. Reporting decisions vary among CPs, and reports may not be interpreted by clinicians as 
intended.  
 
Objectives  The aims of this study were to survey clinicians and CPs about RBC-M terms and their 
clinical value, and identify areas of agreement and discordance.   
  
Methods  Online surveys were distributed to small animal clinicians via the Veterinary Information 
Network and to CPs via the ASVCP listserv. A quiz assessed understanding of RBC-M terms among 
respondent groups. Descriptive statistics were used to analyze responses to survey questions, and quiz 
scores were compared among groups.  
 
Results  Responses were obtained from 1662 clinicians and 82 CPs. Both groups considered some 
terms, e.g., agglutination, useful, whereas only CPs considered other terms, e.g., ghost cells, useful. A 
majority of respondents from both groups interpreted certain terms, e.g., Heinz bodies, correctly, 
whereas a majority of clinicians misinterpreted others, e.g., eccentrocytes. CPs often do not report RBC-
M they consider insignificant, when present in low numbers. Twenty-eight percent of clinicians think 
CPs review all blood smears, while 19% of CPs report reviewing all smears.  
 
Conclusions  Important differences about the clinical relevance of certain RBC-M terms exist between 
clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that 
RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined 
critically to improve communication, transparency, and ultimately medical decisions.    
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Abstract: 
Laryngospasm impedes orotracheal intubation. Traditional neuromuscular blocking agents prevent 
laryngospasm and facilitate intubation, but cause apnea that usually requires mechanical ventilation. 
Gantacurium is a novel, cysteine-inactivated neuromuscular blocker of ultra-short duration. We 
investigated if it can be used to blunt laryngospasm while causing only brief apnea that does not require 
mechanical ventilation and does not cause hemoglobin desaturation. 
 
Eight adult short-hair cats were anesthetized with dexmedetomidine/propofol. Laryngospasm was 
evoked by spraying the larynx with 0.3 mL of sterile water at baseline and after administration of 
gantacurium 0.1, 0.3 and 0.5 mg∙kg-1, IV. The presence or absence of laryngospasm was observed via 
fibroscopy. Duration of apnea and hemoglobin saturation was measured after each laryngeal evaluation.  
The incidence of laryngospasm was 100% at baseline and after gantacurium 0.1 mg∙kg-1. Gantacurium 
0.3 and 0.5 mg∙kg-1 reduced that incidence to 37% (P=0.2) and 0% (P<0.01), respectively. The duration 
of apnea after gantacurium 0.1 mg∙kg-1 was [mean (SE)] 15 (6) seconds, not significantly longer than 
baseline. Gantacurium 0.3 and 0.5 mg∙kg-1 produced apnea of 2 (1) and 3 (1.5) minutes, respectively 
(P<0.001). Hemoglobin desaturation did not occur in any cat. 
 
The results of this study reveal that gantacurium 0.5 mg∙kg-1 can prevent laryngospasm without causing 
prolonged apnea or hemoglobin desaturation in cats. Hence, gantacurium might have a role in improving 
the quality of tracheal intubation while minimizing the risks of apnea and hypoxia. 
  
13 
Annatasha K.G. Bartel, BScH, BVM&S, MRCVS 
abartel@cornell.edu 
 
Institution and location    Degree Year 
Queen’s University, Ontario, Canada   BScH  2002 
University of Edinburgh, Edinburgh, Scotland BVM&S 2008 
Royal College of Veterinary Surgeons, England MRCVS 2008 
Small Animal Rotating Internship, Ontario, Canada Internship 2012 
Cornell University, Ithaca, New York  Residency 2012-present 
 
Current Position: Resident, Anesthesiology, 3rd year 
 
Abstract Title: COMPARISON OF BUPIVACAINE AND DEXMEDETOMIDINE FEMORAL AND 
SCIATIC NERVE BLOCKS VERSUS BUPIVACAINE AND BUPRENORPHINE EPIDURAL FOR 
STIFLE ARTHROPLASTY IN DOGS 
 
Authors Names: 
Annatasha K.G. Bartel1, Luis Campoy1, Manuel Martin-Flores1, Robin D. Gleed1, Kyle J. Walker2, 
Courtney E. Scanapico2, Alison B. Reichard2 
1Department of Clinical Sciences, Cornell University, Ithaca, New York 
2College of Veterinary Medicine Graduate Program, Cornell University, Ithaca, New York 
 
Project Mentor: 
Luis Campoy, LV CertVA, DipECVAA, MRCVS, Department of Clinical Sciences 
 
Abstract: 
Objective  To compare the quality of anesthesia and analgesia of a femoral and sciatic nerve block (FS) 
versus an epidural injection (EPI) in dogs undergoing elective stifle arthroplasty. 
 
Methods  Twenty-six dogs were randomly assigned to groups FS or EPI. Data were collected for a 24h 
period and included  intra-operative  cardiorespiratory  variables,  post-operative  behavioral  variables,  
pain  scores (Glasgow Composite Scale), sedation scores, and opioid consumption. Rescue analgesia 
was administered whenever pain scores were ≥6/24. Additionally, the frequency of adverse side-effects 
was recorded. 
 
Statistical Analyses  Parametric and non-parametric data were analyzed by the two-sample Student’s t-
test and Wilcoxon rank sum test, respectively. For Yes/No variables, e.g. additional analgesia required, 
the Fisher’s exact test was used. Non-parametric continuous data, e.g. time to return to normal 
behaviors, were analyzed by the Wilcoxon rank sum test. 
 
Results  No differences were found amongst any of the variables evaluated. Nine (69%) and eight (61%) 
patients in the FS and EPI groups, respectively, needed no additional analgesia within the 24h 
observation period. Most patients requiring rescue analgesia did so within the first 4h post-recovery; 
only one patient in the EPI group required supplemental analgesia more than 4h after extubation. One 
patient in each group did not urinate for 24h. 
 
Discussion  Our results suggest that either technique has the potential to provide sufficient analgesia for 
up to 24h, however, patient observation is still recommended. All patients in our study met discharge 
criteria at 24h after extubation, based on normal physiological and behavioral parameters as well as 
patient comfort. 
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Abstract Title: 
Introduction  Canine platelet rich plasma (PRP) is used to treat a variety of orthopedic disorders. There 
is little data confirming reproducibility (platelet, red blood cell or white blood cell enrichment) or 
platelet activation status in the various kits utilized.  
 
Material Methods  Venipuncture (cephalic/jugular) was performed on 20 client-owned dogs (all dogs 
over 20 kgs and > 3 years) to examine whole blood and concentrated PRP recovery of all major 
hematological cell types and platelets, utilizing the Terumo APC-30 processing kit.  Platelet activation 
was assessed on fifteen samples (P selectin and Annexin V).  Differences between whole blood and 
PRP, jugular vs cephalic draw PRP, and sedated and unsedated dogs were assessed using student t-tests. 
 
Results  No differences in PRP enrichment were observed based on sedation or site of blood draw.  
Platelet enrichment was approximately 6.2 fold (62.4 + 16.2% recovery).  Red blood cells were 
diminished 2.7 fold (3.7% + 0.9 recovery).  Total WBC enrichment was 3.1 fold (31.2 + 10.3% 
recovery).  Granulocyte and lymphocyte enrichment was 1.9 fold (18.9 + 6.8% recovery) and 5.9 fold 
(58.5% + 10.1 recovery) respectively.  The percentage of platelet activation based on P selectin and 
Annexin V staining was 25.5 + 32.0%; 9.4 + 12.3% for whole blood, and 4.5 + 6.6%; 3.6 + 0.7% for 
PRP, respectively. 
 
Conclusions  Reproducibility of this specific kit was confirmed and platelet activation status 
demonstrated that platelets remain quiescent in PRP.  Although there is modest WBC enrichment, the 
majority are not granulocytes, suggesting that kit can be utilized for quality PRP enrichment. 
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